Loading
Companies fear that testing a combination will hand a competitor a patent. A shared pool where combination patents are cross-licensed by default would remove the fear.
Method-of-use patents on combinations create a hold-up problem: whoever runs the trial may end up owing royalties to the other party or blocking them. Patent pools solved similar problems in DVD and telecoms standards. An oncology combination pool, entered voluntarily with fair, reasonable and non-discriminatory terms, would make combination discovery pre-competitive.
Shares A standard cross-company combination agreement that takes weeks, not years, to sign, Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy, Secrecy and intellectual property block collaboration, Too many combinations to test.
Shares Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy, Too many combinations to test.
Shares Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy, Too many combinations to test.
Shares Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy, Too many combinations to test.
Shares Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy, Too many combinations to test.
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
Shares Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy, Too many combinations to test.
Shares Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy, Too many combinations to test.